Vestal Point Capital, LP - 30 Sep 2025 SCHEDULE 13G/A Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)

Filing Manager: Vestal Point Capital, LP
Reporting Manager: Vestal Point Capital, LP
Security: Astria Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: ATXS
Shares outstanding: 56,318,182 shares
Disclosed Ownership: 4,956,000 shares
Ownership: 8.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:02:07 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vestal Point Capital, LP	8.8%	4,956,000	0	4,956,000	/s/ Ryan Wilder	By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder	8.8%	4,956,000	0	4,956,000	/s/ Ryan Wilder	Ryan Wilder, Individually